Significance of an E-cadherin Gene Promoter Polymorphism for Risk and Disease Severity of Prostate Cancer in a Japanese Population

Urology

Volumn 70, Issue 1, 2007, Pages 127-130

  Goto, Takahiro ^a   Nakano, Masahiro ^a   Ito, Shinichi ^a   Ehara, Hidetoshi ^a   Yamamoto, Naoki ^a   Deguchi, Takashi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK FACTOR;

AGED; CADHERINS; CASE-CONTROL STUDIES; HUMANS; JAPAN; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34447536148     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.036     Document Type: Article

References (23)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin 49 (1999) 8-31
2. Shimizu H., Ross R.K., and Bernstein L. Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn J Cancer Res 82 (1991) 483-485
3. Taylor J.D., Holmes T.M., and Swanson G.M. Descriptive epidemiology of prostate cancer in metropolitan Detroit. Cancer 73 (1994) 1704-1707
4. Oishi K., Yoshida O., and Schroeder F.H. The geography of prostate cancer and its treatment in Japan. Cancer Surv 23 (1995) 267-280
5. Tavtigian S.V., Simard J., Teng D.H., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27 (2001) 172-180
6. Carpten J., Nupponen N., Isaacs S., et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30 (2002) 181-184
7. Carter B.S., Beaty T.H., Steinberg G.D., et al. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 89 (1992) 3367-3371
8. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 22 (1991) 1451-1455
9. Grunwald G.B. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol 5 (1993) 797-805
10. Frixen U.H., Behrens J., Sachs M., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991) 173-185
11. Umbas R., Isaacs W.B., Bringuier P.P., et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54 (1994) 3929-3933
12. Dunsmuir W.D., Gillett C.E., Meyer L.C., et al. Molecular markers for predicting prostate cancer stage and survival. BJU Int 86 (2000) 869-878
13. Li L.C., Chui R.M., Sasaki M., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60 (2000) 873-876
14. Verhage B.A., van Houwelingen K., Ruijter T.E., et al. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100 (2002) 683-685
15. Pookot D., Li L.C., Tabatabai Z.L., et al. The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol 176 (2006) 793-796
16. Hajdinjak T., and Toplak N. E-cadherin polymorphism -160 C/A and prostate cancer. Int J Cancer 109 (2004) 480-481
17. Jonsson B.A., Adami H.O., Hägglund M., et al. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 109 (2004) 348-352
18. Lindström S., Wiklund F., Jonsson B.A., et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Hum Genet 118 (2005) 339-347
19. Bonilla C., Mason T., Long L., et al. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. Prostate 66 (2006) 546-556
20. Tsukino H., Kuroda Y., Imai H., et al. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urol Int 72 (2004) 203-207
21. Kamoto T., Isogawa Y., Shimizu Y., et al. Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population. Jpn J Clin Oncol 35 (2005) 158-161
22. Hirschhorn J.N., Lohmueller K., Byrne E., et al. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
23. Wacholder S., Chanock S., Garcia-Closas M., et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (2004) 434-442